EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.548
https://www.valueinhealthjournal.com/article/S1098-3015(22)00749-5/fulltext
Title :
EE303 Estimating Recurrences Prevented and Costs Avoided with Atezolizumab in Early Non-Small Cell Lung Cancer in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00749-5&doi=10.1016/j.jval.2022.04.548
First page :
Section Title :
Open access? :
No
Section Order :
10492